¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"albumin/creatinine ratio"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® albumin ÇÑ±Û ¾ËºÎ¹Î
¼³¸í   
  1.¹°¿¡ ³ìÀ» ¼ö ÀÖ°í ³ìÀº ÈÄ¿¡ ¿­À» °¡Çϸ頺¯¼ºÀ» ÀÏÀ¸Å°´Â ¸ðµç ´Ü¹éÁúÀÇ ÃÑĪ. 2.Ç÷û ¾ËºÎ¹ÎÀÇ Àǹ̷Π¾²ÀδÙ. Ç÷ûÀ̶õ ÇǸ¦ »Ì¾Æ ¹æÄ¡ÇßÀ» °æ¿ì¿¡ Ç÷¾×ÀÀ°í°¡ µÇ°í ³­ µÚ¿¡ ³²¾ÆÀִ ¸¼Àº ¾×À» ¸»Çϴ µ¥ À̰÷¿¡ ³ì¾ÆÀִ »ç¶÷ÀÇ ´Ü¹éÁúÀ» Ç÷û ´Ü¹éÁúÀ̶ó°í Çϰí ÀÌ Ç÷û´Ü¹éÁúÀÇ ´ëºÎºÐ(60%)À» Â÷ÁöÇϴ °ÍÀÌ ¾ËºÎ¹ÎÀÌ´Ù. ÀÌ ¾ËºÎ¹ÎÀÇ ±â´ÉÀº ¿ì¼± Ç÷¾×¼Ó¿¡ Àִ ¿©·¯ °¡Áö È£¸£¸ó µîÀÇ ¹°Áú°ú °áÇÕÇÏ¿© ±× ¹°ÁúÀÇ ºÐÇØ¸¦ ¸·°í ´Ù¸¥ °÷À¸·Î À̵¿½Ã۴ ¿ªÇÒ°ú Ç÷¾×ÀÇ »ïÅõ¾ÐÀ» À¯ÁöÇϴ ÀÏÀ» ÇÑ´Ù.
¿µ¹® creatinine ÇÑ±Û Å©·¹¾ÆÆ¼´Ñ
¼³¸í   
  ±ÙÀ°, ³ú, ½ÉÀ堵 Á¸ÀçÇÏ¿© ¿¡³ÊÁö¸¦ º¸°üÇϴ ¿ªÇÒÀ» Çϴ ũ·¹¾ÆÆ¾(creatine)À̶ó´Â È¿¼Ò°¡ ´ë»çµÈ ¹°Áú. ´ë°³ Ç÷¾×¼ÓÀ̳ª ±ÙÀ°¿¡ Á¸ÀçÇÏ°í ¶Ç ÄáÆÏÀ» ÅëÇØ¼­ ¸ö¹ÛÀ¸·Î ¹è¼³ÀÌ µÈ´Ù. Ç÷Áß¿¡ Á¸ÀçÇϴ ÀÌ ¹°ÁúÀÇ ³óµµ´Â ´ë°³ º´º¯ÀÌ ¾ø´Â ÇÑ ´ëºÎºÐÀÌ Á¸ÀçÇϴ ±ÙÀ°ÀÇ ¾ç¿¡ ºñ·ÊÇÑ´Ù. ±×¸®°í ÀÌ ¹°ÁúÀº ´Ù¸¥ °æ·Î°¡ ¾øÀÌ ´ÜÁö ÄáÆÏÀ» ÅëÇØ¼­¸¸ ¹èÃâÀÌ µÇ¹Ç·Î ÄáÆÏÀÇ ±â´ÉÀ» Æò°¡Çϴµ¥ ¸¹ÀÌ »ç¿ëÇÑ´Ù.
¿µ¹® creatinine clearance ÇÑ±Û Å©·¹¾ÆÆ¼´Ñ û¼Ò
¼³¸í   
  Ã»¼Ò(clearance)¶õ ÇǼӿ¡¼­ ¾î¶² ¹°ÁúÀ» Á¦°ÅÇϴ ¼Óµµ¸¦ ÀǹÌÇÑ´Ù. ÇǼӿ¡¼­ ¾î¶² ¹°ÁúÀ» Á¦°ÅÇϴ °ÍÀº ÁַΠÄáÆÏÀÇ ¿ªÇÒÀ̹ǷΠÄáÆÏ¿¡¼­ÀÇ ¾î¶² ¹°ÁúÀÌ Á¦°ÅµÇ´Â Ã»¼ÒÀ²ÀÌ ÀÓ»óÀûÀ¸·Î Áß¿äÇÏ´Ù. ÄáÆÏ¿¡¼­ÀÇ ¾î¶² ¹°ÁúÀǠû¼ÒÀ²Àº ´ÙÀ½°ú °°Àº ½ÄÀ¸·Î ±¸ÇØÁø´Ù.
  
  C(creatinine clearance) = V ¡¿ U / P
  
  C¶õ ÄáÆÏÀǠû¼ÒÀ²ÀÇ ¾àÀÚÀ̰í V´Â 1ºÐ´ç ³ª¿À´Â ¼Òº¯ÀÇ ¾çÀ¸·Î ml/minÀ̶õ ´ÜÀ§·Î Ç¥½ÃÇÑ´Ù. ±×¸®°í U¶õ ¼Òº¯¿¡ µé¾î Àִ û¼ÒÀ² ÃøÁ¤ÀÇ ´ë»óÀÌ µÇ´Â ¹°ÁúÀÇ ³óµµÀÌ´Ù. P¶õ Ã»¼ÒÀ² ÃøÁ¤ÀÇ ´ë»óÀÌ µÇ´Â ¹°ÁúÀÇ Ç÷¾× ÁßÀÇ ³óµµ¸¦ ³ªÅ¸³½´Ù. Å©·¹¾ÆÆ¼´Ñ Ã»¼Ò¶õ Å©·¹¾ÆÆ¾À̶ó´Â ¹°ÁúÀǠû¼ÒÀ²À» ³ªÅ¸³»´Â ¸»·Î ÄáÆÏ ±â´ÉÀÇ Æò°¡¿¡ ¸¹ÀÌ »ç¿ëµÇ´Â ÁöÇ¥ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blood urea nitrogen/creatinine ratio
    Ç÷¾×¿ä¼ÒÁú¼Ò/Å©·¹¾ÆÆ¼´Ñºñ
  • serum urea nitrogen/creatinine ratio
    Ç÷û¿ä¼ÒÁú¼Ò/Å©·¹¾ÆÆ¼´Ñºñ
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î³úô¼ö¾×/Ç÷ûºñ
  • albumin-globulin ratio
    ¾ËºÎ¹Î±Û·ÎºÒ¸°ºñ
  • creatinine
    Å©·¹¾ÆÆ¼´Ñ
  • creatinine clearance
    Å©·¹¾ÆÆ¼´Ñû¼ÒÀ²
  • creatinine clearance test
    Å©·¹¾ÆÆ¼´Ñû¼ÒÀ²°Ë»ç
  • albumin
    ¾ËºÎ¹Î
  • bovine serum albumin
    ¼ÒÇ÷û¾ËºÎ¹Î
  • egg albumin
    ´Þ°¿¾ËºÎ¹Î
  • macroaggregated albumin
    ´ëÀÀÁý¾ËºÎ¹Î
  • normal serum albumin
    Á¤»óÇ÷û¾ËºÎ¹Î
  • arm ratio
    µÎÆÈºñ
  • axial ratio
    Ãàºñ
  • abortion ratio
    À¯»êºñ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • albumin
    ¾ËºÎ¹Î
  • creatinine
    Å©·¹¾ÆÆ¼´Ñ
  • creatinine clearance test
    Å©·¹¾ÆÆ¼´Ñû¼ÒÀ²°Ë»ç
  • ratio
    ºñ, À²
  • correlation ratio
    »ó°üºñ
  • inspiratory expiratory ratio
    µé¼û³¯¼ûºñÀ², ÈíÈ£±â´ëºñ
  • odds ratio
    ±³Â÷ºñ
  • scatter-maximum ratio
    ÃÖ´ë»ê¶õºñ
  • segregation ratio
    ºÐ¸®ºñ
  • sex ratio
    ¼ººñ
  • signal-to-noise ratio
    ½ÅÈ£´ëÀâÀ½ºñ
  • uptake ratio
    ¼·ÃëÀ²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blood urea nitrogen/creatinine ratio
    Ç÷¾×´¢¼ÒÁú¼ÒÅ©·¹¾ÆÆ¼´Ñºñ
  • serum urea nitrogen/creatinine ratio
    Ç÷û¿ä¼ÒÁú¼ÒÅ©·¹¾ÆÆ¼´Ñºñ
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î³úô¼ö¾×Ç÷ûºñ
  • albumin-globulin ratio
    ¾ËºÎ¹Î±Û·ÎºÒ¸°ºñ
  • creatinine
    Å©·¹¾ÆÆ¼´Ñ
  • creatinine clearance
    Å©·¹¾ÆÆ¼´Ñû¼Ò
  • creatinine clearance test
    Å©·¹¾ÆÆ¼´Ñû¼ÒÀ²°Ë»ç
  • albumin
    ¾ËºÎ¹Î
  • bovine serum albumin
    ¼ÒÇ÷û¾ËºÎ¹Î
  • egg albumin
    ´Þ°¿¾ËºÎ¹Î
  • macroaggregated albumin
    ´ëÀÀÁý¾ËºÎ¹Î
  • normal serum albumin
    Á¤»óÇ÷û¾ËºÎ¹Î
  • A-G ratio
    (¢¡albumin-globulin ratio) ¾ËºÎ¹Î±Û·ÎºÒ¸°ºñ
  • abortion ratio
    À¯»êºñ
  • age-dependency ratio
    ¿¬·ÉºÎ¾çºñ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • A£¯G ratio=£¾albumin globulin ratio
    A£¯G ºñ.
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î ³úô¼ö¾×/Ç÷û ºñ
  • albumin-globulin ratio =A£¯G r.
    ¾ËºÎ¹Î ±Û·ÎºÒ¸°ºñ.
  • albumin/globulin ratio
    ¾ËºÎ¹Î/±Û·ÎºÒ¸° ºñ
  • Creatinine
    Å©·¹¾ÆÆ¼´Ñ
  • Creatinine clerance
    Å©·¹¾ÆÆ¼´Ñ Á¦°ÅÀ²
  • AC/A ratio->ratio of accommodative convergence to accommodation
    Á¶ÀýÆøÁÖºñ
  • U/S osmol ratio => urine/serum osmol ratio
    ¼Òº¯/Ç÷û ¿À½º¸ôºñ
  • RISA=£¾radioiodinated serum albumin
    ¹æ»ç¼±¿ä¿ÀµåÇ÷û¾ËºÎ¹Î.
  • albumin
    ¾ËºÎ¹Î.
  • albumin
    ¾ËºÎ¹Î
  • albumin
    ¾ËºÎ¹Î
  • albumin agglutinating antibody
    ¾ËºÎ¹ÎÀÀÁýÇ×ü(¡­ëêó¢ù÷ô÷).
  • albumin method
    ¾ËºÎ¹Î¹ý
  • albumin milk
    ¾ËºÎ¹ÎÀ¯.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blood urea nitrogen/creatinine ratio
    Ç÷¾×´¢¼ÒÁú¼Ò/Å©·¹¾ÆÆ¼´Ñ ºñ(À²)
  • serum urea nitrogen/creatinine ratio
    Ç÷û¿ä¼ÒÁú¼Ò/Å©·¹¾ÆÆ¼´Ñ ºñ
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î ³úô¼ö¾×/Ç÷û ºñ
  • albumin-globulin ratio =A£¯G r.
    ¾ËºÎ¹Î ±Û·ÎºÒ¸°ºñ.
  • albumin/globulin ratio
    ¾ËºÎ¹Î/±Û·ÎºÒ¸° ºñ
  • dextrosenitrogen ratio =DN ratio
    Æ÷µµ´çÁú¼Òºñ.
  • creatinine
    Å©·¹¾ÆÆ¼´Ñ.
  • creatinine
    Å©·¹¾ÆÆ¼´Ñ
  • creatinine clearance
    Å©·¹¾ÆÆ¼´ÑÁ¦°Å(¡­ð¶ËÛ).
  • creatinine clearance
    Å©·¹¾ÆÆ¼´Ñ Á¦°Å
  • creatinine clearance
    Å©·¹¾ÆÆ¼´Ñ û¼Ò(Ä¡,À²)
  • creatinine clearance test
    Å©·¹¾ÆÆ¼´ÑÁ¦°Å½ÃÇè(¡­ð¶ËÛãËúÐ).
  • creatinine test
    Å©·¹¾ÆÆ¼´Ñ °Ë»ç
  • serum creatinine
    Ç÷ûũ·¹¾ÆÆ¼´Ñ.
  • albumin
    ¾ËºÎ¹Î.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • albumin/globulin ratio
    ¾ËºÎ¹Î/±Û·ÎºÒ¸° ºñ(Ýï)
  • creatinine
    Å©·¹¾ÆÆ¼´Ñ
  • creatinine coefficient
    Å©·¹¾ÆÆ¼´Ñ °è¼ö(Ìõâ¦)
  • albumin
    ¾ËºÎ¹Î
  • serum albumin
    Ç÷û(úìôè) ¾ËºÎ¹Î
  • absorption ratio
    Èí¼öÀ² (ýåâ¥ëÒ)
  • acceptor-control ratio
    ¼ö¿ëü Á¦¾îÀ² (â¥é»ô÷ ð¤åÙëÒ)
  • affinity ratio
    ģȭºñ(öÑûúÝï)
  • A/G ratio
    A/G ºñ (Ýï)
  • asymmetry ratio
    ºÒ±Õµîºñ (ÝÕгÔõÝï)
  • A+T/G+C ratio
    A+T/G+C ºñ (Ýï)
  • base-pair ratio
    ¿°±â¦ ºñ(Ýï)
  • base ratio
    ¿°±âºñ(ç¤ÐñÝï)
  • channels ratio method
    ä³Î ºñÀ²¹ý(Ýï×ËÛö)
  • coding ratio
    ºÎÈ£ºñ(ݬûÜÝï)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • albumin
    ¾ËºÎ¹Î
  • radioiodinated serum albumin
    ¹æ»ç¼±¿ä¿ÀµåÈ­Ç÷û¾ËºÎ¹Î
  • creatinine
    Å©·¹¾ÆÆ¼´Ñ
  • creatinine clearance
    Å©·¹¾ÆÆ¼´ÑÁ¦°ÅÀ²
  • serum creatinine
    Ç÷ûũ·¹¾ÆÆ¼´Ñ
  • cardiothoracic ratio
    ½ÉÈä(°û)ºñ, ½ÉÈä°è¼ö
  • contrast enhancement ratio
    Á¶¿µÁõ°­ºñ
  • contrast to noise ratio
    ´ëÁ¶ÀâÀ½ºñ
  • depth to width ratio
    ±íÀÌÆøºñÀ²
  • gyromagnetic ratio
    ȸÀüÀÚ±âºñÀ²
  • heart lung ratio
    ½ÉÆó°è¼ö
  • magnetization transfer ratio [=MTR]
    ÀÚÈ­Àü´ÞºñÀ²
  • ratio
    ºñ
  • signal to noise ratio [=SNR]
    ½ÅÈ£´ëÀâÀ½ºñ
  • SNR [=signal to noise ratio]
    ½ÅÈ£´ëÀâÀ½ºñÀ²
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
A/G ratio Albumin/Globulin ratio; ¾ËºÎ¹Î´ë ±Û·ÎºÒ¸°ÀÇ ºñÀ²
ACR Amylase-Creatinine Clearance Ratio
          &...
ACCR amylase-creatinine clearance ratio
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
E/C endocystoscopy; enteric-coated; estrogen/creatinine ratio
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ACR albumin to creatinine ratio
ACR Albumin-creatinine ration
ACCR Amylase-creatinine clearance ratio
L/S ratio Lecithin/sphingomyelin ratio
sCr 1/serum Creatinine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • creatinine
    Å©·¹¾ÆÆ¼´Ñ
    ¿°±â¼º ¹°Áú. Å©·¹¾ÆÆ¾ÀÇ ¹«¼ö¹°À̸ç Å©·¹¾ÆÆ¾ ´ë»çÀÇ ÃÖÁ¾ »ê¹°ÀÌ´Ù. ±ÙÀ°°ú Ç÷¾×¿¡ Á¸ÀçÇÏ¸ç ¼Òº¯À¸·Î ¹è¼³µÈ´Ù.
  • creatinine clearance test
    Å©ºñ¾ÆÆ¼´Ñ Á¦°Å ½ÃÇè
  • albumin
    ¾ËºÎ¹Î
    1. ¹°¿¡ ³ì´Â ´Ü¹éÁúÀÌ°í ¿­¿¡ ÀÇÇØ ÀÀÁýÇÏ°í ¼Ò±Ý¹°¿¡ ÁßÁ¤µµ·Î ÀÀÃàµÈ´Ù. 2. Ç÷Àå ¾ËºÎ¹Î. ´ë·« 60%¸¦ Â÷ÁöÇÏ´Â ÁÖ¿ä Ç÷Àå ´Ü¹éÀ̰í Ç÷Àå »ïÅõ¾ÐÀÇ ´ëºÎºÐÀ» Â÷ÁöÇϰí Áö¹æ»ê, ºñ¸®·çºó, ±×¸®°í ¸¹Àº ¾à¹° ¶Ç ÄÝÆ¼Á¹°ú °©»ó¼± È£¸£¸ó °°Àº °Å´ëÇÑ À¯±â À½ÀÌ¿Â
  • albumin agglutinating antibody
    ¾ËºÎ¹Î ÀÀÁý Ç×ü
  • albumin quotient
    ¾ËºÎ¹Î ºñ
  • macroaggregated albumin
    ´ëÀÀÁý ¾ËºÎ¹Î
    ´ëÀÀÁýÀÎ Ç÷û ¾ËºÎ¹Î. Á¤¸Æ ÁÖ»çÇÏ¸é ¸ð¼¼°ü¿¡ ü·ùÇÏ´Â ¼ºÁúÀ» ÀÌ¿ëÇØ¼­
  • radioiodinated serum albumin
    ¹æ»ç¼± ¿ä¿ÀµåÈ­ Ç÷û ¾ËºÎ¹Î
  • serum albumin
    Ç÷û ¾ËºÎ¹Î
    Ç÷û Áß ÃÑ ´Ü¹éÁúÀÇ ¾à 60%¸¦ Â÷ÁöÇÏ°í »ý¸®ÇÐÀû ¿ªÇÒÀº »ïÅõ¾ÐÀÇ À¯ÁöÀÌ´Ù.
  • air entrainment ratio
    °ø±â À¯ÀÔ·ü
  • benefit/risk ratio
    À¯ÀÍ/À¯ÇØ ºñÀ²
  • body-weight ratio
    üÁß ½ÅÀå ºñ
  • cardiothoracic ratio
    ½ÉÈäºñ, ½ÉÈä°û ºñ, ½ÉÈä °è¼ö
  • cell color ratio
    Ç÷±¸»ö¼Òºñ, ÀûÇ÷±¸ »ö¼Òºñ
  • child woman ratio
    ¸ð¾Æ ºñÀ²
  • crown-root ratio
    Ä¡°ü´ë Ä¡±Ùºñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
amylase-creatinine clearance ratio A test for the diagnosis of acute pancreatitis; it is determined by measuring amylase and creatinine in serum and urine in apparently healthy individuals the renal clearance of amylase is less than 5% that of creatinine; in acute pancreatitis the ratio is said to be greater than 0.05 or 5%.
(05 Mar 2000)
albumin-globulin ratio The ratio of albumin to globulin in the serum or in the urine in kidney disease; the normal ratio in the serum is approximately 1.55.
(05 Mar 2000)
creatinine <biochemistry, nephrology> A waste product of protein metabolism that is found in the urine.
Can be measured to assess overall kidney function. An abnormally elevated blood creatinine level is seen in those individuals with kidney insufficiency and kidney failure.
(27 Sep 1997)
creatinine clearance Measurement of the clearance of endogenous creatinine, used for evaluating the glomerular filtration rate (GFR).
(05 Mar 2000)
creatinine clearance test <investigation, nephrology> A test of the amount of creatinine in blood or in blood and urine shows if the kidneys are working right or if one or both are diseased.
(09 Oct 1997)
creatinine coefficient The number of milligrams of creatinine excreted daily per kilogram of body weight.
(05 Mar 2000)
creatinine deiminase <enzyme> Enzyme sometimes called creatininase, do not confuse with EC 3.5.2.10
Registry number: EC 3.5.4.21
Synonym: creatinine iminohydrolase, creatine iminohydrolase
(26 Jun 1999)
endogenous creatinine clearance A term distinguishing measurements based on the creatinine normally present in plasma; since no infusion is necessary, an average value may be obtained by collecting urine for a long period, e.g., 24 hours.
(05 Mar 2000)
exogenous creatinine clearance A term distinguishing measurements based on infusing creatinine intravenously to raise its plasma concentration and facilitate its accurate chemical determination.
(05 Mar 2000)
acetosoluble albumin A substance resembling serum albumin, but soluble in acetic acid.
Synonym: acetosoluble albumin.
(05 Mar 2000)
albumin 1. <chemistry> Any protein that is soluble in water and moderately concentrated salt solutions and is coagulable by heat. Found in egg whites, blood, lymph, and other tissues and fluids.
2. <biochemistry> Serum albumin, the major plasma protein (approximately 60 per cent of the total), which is responsible for much of the plasma colloidal osmotic pressure and serves as a transport protein carrying large organic anions, such as fatty acids, bilirubin and many drugs and also carrying certain hormones, such as cortisol and thyroxine, when their specific binding globulins are saturated.
Albumin is synthesised in the liver. Low serum levels occur in protein malnutrition, active inflammation and serious hepatic and renal disease.
(31 Jan 2000)
albumin A The normal or common type of human serum albumin.
(05 Mar 2000)
albumin B Types of human serum albumin, distinguished by characteristic mobility patterns on electrophoresis; each type is due to a mutation of a gene controlling albumin synthesis; the mutant genes are codominant with the normal gene for albumin A, and the group forms a system of genetic polymorphism; types include: albumin b (slow), found occasionally in persons of European ancestry; albumin Ghent (fast), found first at Ghent, Belgium; albumin Mexico (slow), found in Indians of Mexico and the southwestern United States; albumin Naskapi (fast), found in the Naskapi and other Indians of northern North America; and albumin Reading (fast), found first at Reading, England.
(05 Mar 2000)
albumin Ghent Types of human serum albumin, distinguished by characteristic mobility patterns on electrophoresis; each type is due to a mutation of a gene controlling albumin synthesis; the mutant genes are codominant with the normal gene for albumin A, and the group forms a system of genetic polymorphism; types include: albumin b (slow), found occasionally in persons of European ancestry; albumin Ghent (fast), found first at Ghent, Belgium; albumin Mexico (slow), found in Indians of Mexico and the southwestern United States; albumin Naskapi (fast), found in the Naskapi and other Indians of northern North America; and albumin Reading (fast), found first at Reading, England.
(05 Mar 2000)
albumin Mexico Types of human serum albumin, distinguished by characteristic mobility patterns on electrophoresis; each type is due to a mutation of a gene controlling albumin synthesis; the mutant genes are codominant with the normal gene for albumin A, and the group forms a system of genetic polymorphism; types include: albumin b (slow), found occasionally in persons of European ancestry; albumin Ghent (fast), found first at Ghent, Belgium; albumin Mexico (slow), found in Indians of Mexico and the southwestern United States; albumin Naskapi (fast), found in the Naskapi and other Indians of northern North America; and albumin Reading (fast), found first at Reading, England.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • albumin
    ¾ËºÎ¹Î
  • creatinine
    Å©·¹¾ÆÆ¼´Ñ(ôÃßµ¿¹°ÀÇ ±ÙÀ°.¿ÀÁÜ.Ç÷¾× ¼ÓÀÇ ¹é»ö °áÁ¤)
  • ratio
    ºñ
  • cash ratio
    (ÀºÇàÀÇ ÁöºÒ Áغñ±ÝÀÇ ÃÑ¿¹±Ý¿¡ ´ëÇÑ)Çö±Ý ºñÀ²
  • compression ratio
    (¿£ÁøÀÇ) ¾ÐÃàºñ
  • conversion ratio
    Àüȯ ºñÀ²(Çٺп­½Ã ÇϳªÀÇ ¿øÀÚ¿¡¼­ »ý±â´Â ¿øÀÚÀÇ ¼ö
  • cost performance (ratio)
    ºñ¿ë´ë ¼º´Éºñ
  • direct ratio
    (¼ö)Á¤ºñ;Á¤ºñ·Ê
  • elderly dependency ratio
    ³ë·ÉÀÚ(ÇÇ)ºÎ¾ç·ü
  • focal ratio
    =F-NUMBER
  • inverse ratio
    (¼ö)¹Ýºñ;¿ªºñ
  • mass ratio
    Áú·®ºñ (ÃßÁøºÎ¸¦ Á¦¿ÜÇÑ ·ÎÄÏ º»Ã¼¿¡ ´ëÇÑ ÃÑÁß·®ÀÇ ºñÀ²,ÃßÁø¾à ÃæÀüÀ²)
  • payout ratio
    ¹è´ç ¼ºÇâ
  • priceearnings ratio
    ÁÖ°¡ ¼öÀÍ·ü 9
  • ratio
    ºñ;ºñÀ²
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á